Vyvgart (efgartigimod alfa)

pCPA File Number: 22530
Negotiation Status:
Active Negotiation
Indication(s):
Generalized myasthenia gravis (gMG)
Sponsor/Manufacturer:
Argenx Canada Inc.
CDA-AMC Project Number:
SR0782-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable